Boryung wins patent nullification trial over Arimidex

The local patent trial board has recently ruled against AstraZeneca’s Arimidex (anastrozole) patent in its nullification trial which has been sought by Boryung Pharm.

Anastrozole is a drug used to treat breast cancer after surgery and for metastases in post-menopausal women. Anastrozole is an aromatase inhibitor, which means that it interrupts a critical step in the body's synthesis of estro...